Regenerative Medicine Market is valued at around USD 16148.16 Million in 2017 and expected to reach USD 74831.35 Million by 2024 with the CAGR of 22.27% over the forecast period.
Global regenerative medicines market report covers prominent players like Stryker Corporation, Cook Biotech Inc., Vericel Corporation, DePuy Synthes, Inc. Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, Inc., NuVasive, Inc., Acelity (KCI Concepts), Zimmer Holdings, Inc., Integra LifeSciences, C.R. Bard and others.
Regenerative medicines are those medicines which are used to repair, regenerate, and replace the tissues or organs damaged due to disease, injury or natural aging. Regenerative medicines are used in the treatment of various disorders such as orthopedic, neurodegenerative, oncology and others. These medicines help in the restoration of natural functioning of the organs and tissues. Regenerative medicines can also be used for the treatment of various chronic and genetic disorders, it also helps in the treatment of organ transplant which has reduced the rejection cases to a major extent.
Osiris Therapeutics established in 1992 and, based in Columbia, Maryland.
Osiris Therapeuticsis the world leader in researching, developing and marketing regenerative medicine products. Having developed the world’s first approved stem cell drug, the company continues to advance its research and development in biotechnology by focusing on innovation in regenerative medicine – including bioengineering, stem cell research and viable tissue based products. Osiris has achieved commercial success with products in orthopaedics, sports medicine and wound care, including BIO4™, Cartiform® and Grafix®.
Organogenesis was established 1985 and headquarter in in Canton, Massachusetts.
Specialties in Regenerative Medicine, Bio-Active Wound Healing, Soft Tissue Regeneration, Surgical Biologics, and Orthopedics and Spine
Organogenesis Inc. is a global leader in regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’ versatile portfolio is designed to treat a variety of patients with repair and regenerative needs
Medtronic established in 1949 and headquarter in Minneapolis, MN
Medtronic is a global healthcare solutions company operating in approximately 160 countries and committed to improving lives through our medical technologies, services, and solutions.
News: Medtronic Receives FDA "Breakthrough Device Designation" for TYRX Driveline Wrap Device
DePuy Synthes Companies headquarter in Raynham, MA
The DePuy Synthes Companies offer the world’s most comprehensive portfolio of orthopaedic and neuro products and services for joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials.
News: Ethicon Launches Novel, Easy-to-use Staple Line Reinforcement Device for Bariatric, Thoracic and General Surgery
Specialties in Biologics, Cell Therapy, Clinical Research, Multicellular Therapy Development, Clinical Trials, and Automated cell-processing system
Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions
Cook Biotech Established in 1995 and headquarter in West Lafayette, USA
Cook Biotech Incorporated, a world leader in regenerative medicine, develop and manufacture biologic tissue grafts utilizing extracellular matrix (ECM) technology. Cook Biotech products have been used in more than 1.5 million soft-tissue-repair treatments worldwide, including treatment for fistulas, hernias, and wounds.
Stryker established in 1941 and headquarter in Kalamazoo, MI
Specialties in medical Instruments & Supplies, medical devices, medical technology, and Surgical Instruments
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
Interested in this report?
26 Feb 2021